Virax Biolabs Group Ltd

Company Profile

• Business description

  Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.

• Contact

  Bo’Ness Road Newhouse
  BioCity Glasgow
  Lanarkshire
  MotherwellML1 5UH
  GBR

  T: +44 2077887414

  https://www.viraxbiolabs.com

• Sector

  Healthcare

  Stock type

  Defensive

• Industry

  Biotechnology

  Fiscal Year End

  31 March 2027

  Employees

  26